Results 151 to 160 of about 462,808 (314)
FeiFang Deng,1,2 Peng Wang2 1Women and Children’s Health Care Hospital of Luohu, Shenzhen, People’s Republic of China; 2Department of Dermatology, Affiliated Nanshan Hospital of Shenzhen University (Shenzhen Nanshan People’s Hospital), Shenzhen ...
Deng F, Wang P
doaj
Aims Graduating medical students consistently report being unprepared for the complexity of prescribing in clinical practice. Current clinical prescribing teaching and authentic assessment are limited due to patient safety concerns. We aimed to examine the educational utility of supervised preprescribing as a learning process and potential authentic ...
Kellie A. Charles +7 more
wiley +1 more source
Maoying Li,1 Xi Wang,2 Jiehui Chen,2 Tao Deng,2 Cuihong Lian3 1Department of Dermatology and Venereology,Guanxi University of Chinese Medicine, Nanning, 530000, People’s Republic of China; 2Department of Dermatology and Venereology,The First Clinical ...
Li M, Wang X, Chen J, Deng T, Lian C
doaj
'I Didn't Know, I Definitely Guessed.' Exploring Pre-Registration Podiatry Students' Approach to Identifying Dermatological Conditions in Different Skin Tones, a Mixed Methods Study. [PDF]
Otter S +5 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Haiyan Cheng,1 Meng Jiang,1 Shan Zhong,1 Xinhai Liu,2 Dongsheng Cao,3 Qiuyuan Feng,4 Yongzhong Li,5 Wei Xu1 1Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Plastic ...
Cheng H +7 more
doaj
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis). [PDF]
Pezzolo E +34 more
europepmc +1 more source
Dermatologic emergencies [PDF]
Anatoli, Freiman +2 more
openaire +2 more sources
Abstract Aims Population pharmacokinetic (popPK) and pharmacokinetic‐pharmacodynamic (PK/PD) models were developed to support clinical development of nemolizumab, a humanized monoclonal antibody targeting the IL‐31 receptor α, in adolescents and adults with moderate‐to‐severe atopic dermatitis (AD).
Floris Fauchet +17 more
wiley +1 more source

